Associated Papers
Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan.
Tada H et al.
Journal of Atherosclerosis and Thrombosis, 2024
Analysis of the low density lipoprotein receptor gene (LDLR) mutation spectrum in Russian familial hypercholesterolemia.
Vasilyev VB et al.
Vavilovskii Zhurnal Genetiki I Selektsii, 2022
Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia.
Tada H et al.
Frontiers in Genetics, 2022
35480308 (PubMed )
Supplement: Presentation1.pdf
The LDLR, APOB, and PCSK9 Variants of Index Patients with Familial Hypercholesterolemia in Russia.
Meshkov A et al.
Genes, 2021
[The Familial Hypercholesterolemia Caused by a Novel Human Low Density Lipoprotein Receptor Gene Mutation c.1327 T>C (p.W433R)].
Korneva VA et al.
Kardiologiia, 2017
Cholesterol Levels in Genetically Determined Familial Hypercholesterolaemia in Russian Karelia.
Korneva VA et al.
Cholesterol, 2017
[Clinical signs of homozygous familial hypercholesterolemia].
Malyshev PP et al.
Kardiologiia, 2002
[Current concepts of the pathogenesis of familial hypercholesterolemia].
Khandaker AKh et al.
Kardiologiia, 1988
Select a paper to view details